Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as  GLP-1s.

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

A WOMAN who lost five stone in nine months on fat jabs has admitted there’s a “painful” side effect that no-one warned her ...

The growing interest in Mounjaro shows an increasing awareness of metabolic health, which is a positive trend. However, ...